Business ❯ Market Trends

Pharmaceutical Industry

Competition Investment Strategies Drug Pricing Weight Loss Drugs Mergers and Acquisitions Investment Opportunities Competitors Sales Performance Investment Product Launches

Eli Lilly Trades at a High Multiple as GLP‑1 Catalysts Loom

Near‑term regulatory decisions and launch results will determine whether investors’ big growth bet on the company is justified.

Viking Therapeutics Rallies as Weight‑Loss Program Moves Toward Late‑Stage Testing

CVS Caremark Reverses Exclusion and Adds Lilly’s Foundayo and Zepbound to Its Formulary

Novo Nordisk Lifts 2026 Outlook as Wegovy Pill Powers Big Q1 Beat

Novo Nordisk Lifts Outlook After Wegovy Pill Fuels Q1 Beat

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

FDA Clears Wegovy Weight-Loss Pill, U.S. Launch Set for January

Pfizer Sues to Block Novo Nordisk’s Higher Metsera Bid as Board Backs Revised Offer

Siegwerk Launches Mineral Oil‑Free Inks for India’s Pharma Packaging Market

Sartorius Lifts Outlook as Growth Rebounds and Hiring Resumes

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

Novo Nordisk to Cut 9,000 Jobs, Lowers Profit Outlook in Global Restructuring

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Farmacity Explores Passive Investor or IPO to Fund Growth

Merck Completes €3 Billion Springworks Deal in Largest Pharma Acquisition Since 2007

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront